Parathyroid hormone.
Madore
Gigi R
GR
Weill Medical College of Cornell University, New York, NY, USA.
Sherman
Pamela J
PJ
Lane
Joseph M
JM
D000368:Aged; D019386:Alendronate / Q000627:therapeutic use; D015519:Bone Density / Q000187:drug effects; D016723:Bone Remodeling / Q000187:drug effects / Q000502:physiology; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D012968:Etidronic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D005598:Fractures, Spontaneous / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000175:diagnosis / Q000188:drug therapy; D015663:Osteoporosis, Postmenopausal / Q000175:diagnosis / Q000188:drug therapy*; D010281:Parathyroid Hormone / Q000627:therapeutic use*; D000068296:Risedronic Acid; D018570:Risk Assessment; D019379:Teriparatide / Q000627:therapeutic use; D016896:Treatment Outcome
D010281:Parathyroid Hormone; D019379:Teriparatide; D000068296:Risedronic Acid; D012968:Etidronic Acid; D019386:Alendronate